Business Information
The group's principal activity is to provide drug discovery and development services. The development sciences segment provides preclinical programs. The activities of the discovery sciences include functional genomics, which is the study of gene functions to identify drug targets within the body. This segment also provides biological chemistry research and preclinical biology services. It offers post-Market support services for drugs receiving approval for market use. These services include product launch services, patient compliance programs and medical communications programs for consumer and healthcare providers on product use and adverse events. In 2002, the group acquired medical research laboratories international inc, medical research laboratories international bvba, piedmont research center ii inc, complete software solutions inc and propharma pte ltd. In jul 2003, the group acquired eminent research systems inc and clinsights inc.
|
|
Name |
Title
|
Email
|
| Fred Davenport | Pres., Assist. Sec. | N/A | | Fred Eshelman | Vice Chmn., CEO | N/A | | Linda Baddour | CFO, Treasurer, Assist. Sec. | N/A | | Peter Wilkinson | Chief Accounting Officer | N/A | | William Sharbaugh | COO | N/A |
|
|
Year |
Sales |
Net Income |
| 2006 | 1,247,682 | 156,652 | | 2005 | 1,037,090 | 131,483 | | 2004 | 841,256 | 98,888
|
|
| TO SEE COMPLETE RESULTS SUBSCRIBE NOW |
TO SEE COMPLETE RESULTS SUBSCRIBE NOW |
|
Click for more Executives |
|
|
